Clonal hematopoiesis, aging, and cardiovascular diseases.

Abstract:

:Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Many studies have provided evidence that both genetic and environmental factors induce atherosclerosis, leading thus to cardiovascular complications. Atherosclerosis is an inflammatory disease, and aging is strongly associated with the development of atherosclerosis. Recent experimental evidence suggests that clonal hematopoiesis (CH) is an emerging cardiovascular risk factor that contributes to the development of atherosclerosis and cardiac dysfunction and exacerbates cardiovascular diseases. CH is caused by somatic mutations in recurrent genes in hematopoietic stem cells, leading to the clonal expansion of mutated blood cell clones. Many of the mutated genes are known in the context of myeloid neoplasms. However, only some individuals carrying CH mutations develop hematologic abnormalities. CH is clearly age dependent and is not rare: at least 10%-20% of people >70 years old carry CH. The newly discovered association between myeloid leukemia-driver mutations and the progression of CVDs has raised medical interest. In this review, we summarize the current view on the contribution of CH in different cardiovascular diseases, CVD risk assessment, patient stratification, and the development of novel therapeutic strategies.

journal_name

Exp Hematol

journal_title

Experimental hematology

authors

Pardali E,Dimmeler S,Zeiher AM,Rieger MA

doi

10.1016/j.exphem.2019.12.006

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

95-104

eissn

0301-472X

issn

1873-2399

pii

S0301-472X(19)31241-X

journal_volume

83

pub_type

杂志文章,评审